Nasdaq
TLX
Telix Pharmaceuticals Limited
- Health Care
- Australia
- 1 day
- +2.1%
- 1 month
- −9.4%
- 1 year
- −11.1%
$10.64 · Mkt cap $3.60B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Telix Pharmaceuticals Limited
$10.64 · Mkt cap $3.60B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Telix Pharmaceuticals Limited trades under the ticker TLX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $3.60B. The last closing price was $10.64, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −11.1%, and −9.4% over the past month. Returns are price returns and exclude dividends.
This page exists because TLX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.